TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Bionomit Public AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1
|
5
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-8
|
0
|
-296 |
| EBITDA |
-8
|
0
|
-5 |
| Total assets |
428
|
447
|
444 |
| Current assets |
8
|
9
|
4 |
| Current liabilities |
13
|
9
|
9 |
| Equity capital |
412
|
435
|
431 |
| - share capital |
44
|
45
|
45 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
96.3%
|
97.3%
|
97.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-800%
|
0% | |
| Return on assets (ROA) |
-1.9%
|
0%
|
-66.7% |
| Current ratio |
61.5%
|
100%
|
44.4% |
| Return on equity (ROE) |
-1.9%
|
0%
|
-68.7% |
| Change turnover |
-4
|
5
|
0 |
| Change turnover % |
-79%
|
6000%
|
-50% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.